Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1044 Results

View

Closed

Phase

Accrual

57%

Published

SWOG Clinical Trial Number

SWOG-8726

Evaluation of Amonafide in Refractory Multiple Myeloma

Activated

04-01-1988

Closed

11-01-1989

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8800

Evaluation of Pibenzimol in Advanced Pancreatic Adenocarcinoma

Activated

04-01-1988

Closed

05-01-1989

Closed

Phase

Accrual

69%

Published

SWOG Clinical Trial Number

SWOG-8711

A Study of Reproductive Function in Patients with Testicular Cancer

Research Committee(s)

Genitourinary Cancer

Activated

04-01-1988

Closed

06-01-1994

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8804

Evaluation of Cis-Platinum and DTIC in Inoperable Stage lll and Stage IV Melanoma

Activated

04-01-1988

Closed

06-01-1990

Closed

Phase

Accrual

30%

Published

SWOG Clinical Trial Number

SWOG-8803

A Six Course Alternating Combination Regimen in Advanced Previously Untreated Head and Neck Cancer Patients

Activated

04-01-1988

Closed

05-01-1990

Closed

Phase

SWOG Clinical Trial Number

SWOG-8700

Consolidation Therapy with High-Dose Cyclophosphamide and Total Body Irradiation, Followed by Autologous Marrow Infusion in Metastatic Breast Cancer, Phase II

Research Committee(s)

Breast Cancer

Activated

04-01-1988

Closed

01-01-1989

Closed

Phase

Accrual

57%

SWOG Clinical Trial Number

SWOG-8735

A Phase II Study of Recombinant Human Interferon- Alpha and Recombinant Human Interferon-Gamma in Previously Untreated Patients with Chronic Myelogenous Leukemia

Activated

04-01-1988

Closed

05-15-1990

Closed

Phase

Accrual

23%

Published

SWOG Clinical Trial Number

SWOG-8706

A Prospective Study of Three Post-Remission Therapies in Adult Acute Nonlymphocytic Leukemia: Allogeneic Transplantation vs. Autologous Transplantation vs. Consolidation Chemotherapy

Research Committee(s)

Leukemia

Activated

04-01-1988

Closed

12-15-1990

Closed

Phase

Accrual

77%

Published

SWOG Clinical Trial Number

SWOG-8733

Evaluations of Operable Bladder Cancer Patients with Pre-Operative Irradiation + 5-FU and Inoperable Patients With Irradiation + 5-FU Alone, Phase II, A Pilot Study for Patients Ineligible for SWOG-8710

Research Committee(s)

Genitourinary Cancer

Activated

04-01-1988

Closed

02-15-1997

Closed

Phase

Accrual

92%

Published

SWOG Clinical Trial Number

SWOG-8810

Six Courses of 5-Fluorouracil and Cis-Platinum With Correlation of Clinical and Cellular DNA Parameters in Patients with Advanced, Untreated and Unresectable Squamous Cell Carcinoma of the Head and Neck

Activated

04-01-1988

Closed

12-15-1992

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8736 (INT-0093)

Treatment of Localized Non-Hodgkin's Lymphoma: Comparison of Chemotherapy (CHOP) to Chemo-therapy Plus Radiation Therapy

Research Committee(s)

Lymphoma

Activated

03-15-1988

Closed

06-15-1995

Closed

Phase

Accrual

97%

Published

SWOG Clinical Trial Number

SWOG-8515

Reactivated (unfavorable histology only): 4/15/90, Temporarily Closed (unfavorable histology only): 11/1/89 Evaluation of Menogaril (NSC-269148) in Non-Hodgkin's Lymphoma

Research Committee(s)

Lymphoma

Activated

03-15-1988

Closed

12-15-1991

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8715

Evaluation of Amonafide in Advanced Sarcomas

Activated

03-01-1988

Closed

02-01-1990

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8731

Ifosfamide and Mesna in Malignant Mesothelioma

Activated

03-01-1988

Closed

07-15-1989

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8714

Evaluation of Amonafide in Colorectal Carcinoma

Activated

03-01-1988

Closed

05-01-1989

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8732

Evaluation of Amonafide in Endometrial Carcinoma

Activated

03-01-1988

Closed

03-01-1991

Closed

Phase

Accrual

86%

Published

SWOG Clinical Trial Number

SWOG-8734

Phase ll Trial of Low Dose PALA and High Dose 5-FU as a Short Term Infusion in the Treatment of Adeno-carcinoma of the Stomach

Research Committee(s)

Gastrointestinal Cancer

Activated

03-01-1988

Closed

01-01-1990

Closed

Phase

Accrual

77%

Published

SWOG Clinical Trial Number

SWOG-8729

Phase II Trial of Low Dose PALA and High Dose 5-FU as a Short Term Infusion in the Treatment of Adeno-carcinoma of the Pancreas

Activated

03-01-1988

Closed

01-01-1990

Closed

Phase

Accrual

53%

Published

SWOG Clinical Trial Number

SWOG-8790 (INT-0083) (GOG-133)

A Randomized Trial of Adjuvant Intraperitoneal Recombinant Interferon Alpha-2 in Stage III Ovarian Carcinoma in Patients Who Have No Evidence of Disease After Surgery and Chemotherapy

Research Committee(s)

Gynecologic Cancer

Activated

03-01-1988

Closed

06-15-1999

Closed

Phase

Accrual

20%

SWOG Clinical Trial Number

SWOG-8621

Chemo-Hormonal Therapy of Postmenopausal Receptor-Positive Breast Cancer

Activated

02-01-1988

Closed

08-01-1991